RadNet (RDNT) Morgan Stanley 24th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley 24th Annual Global Healthcare Conference summary
16 Sep, 2026Industry landscape and consolidation
Diagnostic imaging remains highly fragmented, with top five players owning less than 20% of the market, leaving significant room for consolidation and growth over the coming years.
Scale provides operational advantages, especially in IT, revenue cycle, and labor cost management, making consolidation increasingly attractive.
Most centers are small, radiologist-owned facilities lacking scale benefits, which is critical amid rising labor costs.
Reimbursement trends and regulatory environment
Medicare reimbursement for outpatient diagnostic imaging has been stable, with a slight increase in 2026 and net neutral expectations for the following year.
Regional concentration enables stronger negotiation with commercial insurers, resulting in annual reimbursement increases that help offset inflation.
Site-neutral payment initiatives, if implemented, could disrupt hospital-based imaging but benefit lower-cost outpatient providers.
Organic growth and technology initiatives
Operational initiatives include expanding hours and weekend operations to meet growing demand and manage backlogs, especially in advanced imaging.
Technology investments, such as faster scanners and digital health tools, increase capacity and throughput.
Remote scanning technology (TechLive) enables flexible staffing, contributing to over 10% same-store MRI growth in Q2.
AI-driven ultrasound solutions have reduced exam and reporting times by up to 50%, increasing capacity and generating new revenue via Category III codes.
Latest events from RadNet
- Digital health and imaging growth, AI-driven productivity, and expanding partnerships fuel strong outlook.RDNT
2026 Jefferies Healthcare Services and Technology Conference - Record revenue and EBITDA, strong Digital Health growth, and raised guidance mark robust results.RDNT
Q2 2026 - Advanced imaging, AI, and acquisitions drive robust growth and margin expansion for 2026.RDNT
47th Annual Raymond James Institutional Investor Conference - AI-powered imaging and outpatient expansion drive double-digit growth and industry leadership.RDNT
44th Annual J.P. Morgan Healthcare Conference - Record revenue and EBITDA growth, AI expansion, and acquisitions led to raised 2025 guidance.RDNT
Q3 2025 - Advanced imaging and digital health drive robust growth, with major AI and OEM partnerships announced.RDNT
Bank of America Securities 2024 Leveraged Finance Conference - Record Q2 revenue and EBITDA, strong AI growth, and raised 2024 guidance amid cost pressures.RDNT
Q2 2024 - $103M all-stock deal forms a global AI breast imaging leader, targeting $7M+ cost synergies.RDNT
M&A Announcement - Q1 revenue up 9.2%, guidance raised, and iCAD acquisition to expand AI breast health.RDNT
Q1 2025